These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5029384)

  • 1. Effect of brain lesions and chlorpromazine on accumulation and disappearance of catecholamines formed in vivo from 14 C-tyrosine.
    Nybäck H
    Acta Physiol Scand; 1972 Jan; 84(1):54-64. PubMed ID: 5029384
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment.
    Fyrö B; Nybäck H; Sedvall G
    Neuropharmacology; 1972 Jul; 11(4):531-7. PubMed ID: 4403078
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 5. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.
    Nybäck H; Sedvall G
    J Pharmacol Exp Ther; 1968 Aug; 162(2):294-301. PubMed ID: 5666984
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine.
    Nybäck H; Sedvall C
    J Pharm Pharmacol; 1971 May; 23(5):322-6. PubMed ID: 4397399
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
    Nybäck H
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):372-84. PubMed ID: 4401187
    [No Abstract]   [Full Text] [Related]  

  • 9. Norepinephrine and dopamine in the corpus striatum and remainder of the brain following phenothiazine treatment.
    Angelakos ET; McKenna OC
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):288-92. PubMed ID: 5895686
    [No Abstract]   [Full Text] [Related]  

  • 10. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 13. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs.
    Nybäck H; Borzecki Z; Sedvall G
    Eur J Pharmacol; 1968 Nov; 4(4):395-403. PubMed ID: 5724916
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
    Marsden CA; Guldberg HC
    Neuropharmacology; 1973 Mar; 12(3):195-211. PubMed ID: 4266877
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues.
    Nybäck H; Sedvall G
    Eur J Pharmacol; 1970 May; 10(2):193-205. PubMed ID: 5446375
    [No Abstract]   [Full Text] [Related]  

  • 16. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 17. Acceleration of turnover of 14C-catecholamines in rat brain by chlorpromazine.
    Gey KF; Pletscher A
    Experientia; 1968 Apr; 24(4):335-6. PubMed ID: 5705176
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-specific histopathological changes induced by the intracerebral injection of 6-hydroxy-dopamine (6-OH-DA).
    Poirier LJ; Langelier P; Roberge A; Boucher R; Kitsikis A
    J Neurol Sci; 1972 Aug; 16(4):401-16. PubMed ID: 5049103
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain.
    Nybäck H; Sedvall G
    Psychopharmacologia; 1972; 26(2):155-60. PubMed ID: 5073041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.